MicroPort Hong Kong Public Offering 224 Times Oversubscribed
Offer price set at HK$6.10 per share
Trading debuts on 24 September
HONG KONG, 21 September 2010--MicroPort Scientific Corporation ("MicroPort" or "the Company"), a leading developer, manufacturer and marketer of medical devices in China minimally invasive interventional products for the treatment of vascular diseases and disorders, has received more than 224 times oversubscription in the Hong Kong Public Offering. The offer price of its Global Offering has been set at HK$6.10 per share, the top end of the indicative price range. The amount of the net proceeds from the Global Offering before exercise of the over- allotment option is approximately HK$1,428.3 million.
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.
For more information, please see our Cookie Policy.